论文部分内容阅读
缺血性脑血管病(ICVd)为临床常见疾病,根据全国流行病学调查,近年来ICVD有发病率上升及发病年龄年轻化的趋势,给个人和社会造成了严重负担。目前用于临床的药物种类较多,但疗效不够确切,且多为复方酶制剂。深圳海王降纤酶为新型强力溶血栓改善微循环治疗剂,本品系长白山中眉蝮蛇毒中提取的单成分蛋白水解酶加适量稳定剂和赋形剂的无菌冻干品,分子量约36000,它除具有降低血浆纤维蛋白、血液粘度和血小板聚集作用,还具有改善微循环的作用,可以抑制红血球的凝聚力,缩短血球通过时间,增加血液流动性,降低血管阻力,增加血液量,从而防止血栓形成或血栓增长。我们用海王降纤
Ischemic cerebrovascular disease (ICVd) is a common clinical disease. According to the national epidemiological survey, in recent years, the incidence of ICVD has risen and the age of onset has become younger, posing a heavy burden to individuals and society. Currently used in clinical medicine more, but the effect is not exact enough, and mostly compound enzyme preparation. Shenzhen Haiwang defibrase for the new powerful thrombolytic agents to improve microcirculation, the strain of Changbai Mountain snakehead snake venom extract single component of proteolytic enzymes plus appropriate amount of stabilizer and excipient sterile lyophilized product, a molecular weight of about 36000 , In addition to reducing plasma fibrin, blood viscosity and platelet aggregation, but also has the effect of improving microcirculation, can inhibit the cohesion of red blood cells, shorten the blood cell passage time, increase blood flow, reduce vascular resistance, increase blood volume, thereby preventing Thrombosis or thrombosis. We use the sea king fiber